Tucson Morning Blend


New hope for some cancer patients

Posted at 12:33 PM, Jul 21, 2020
and last updated 2020-07-21 15:33:38-04

Despite recent progress in treating lung cancer, it remains the leading cause of cancer death in the U.S. as of 2019. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 84% of diagnoses.

People affected by this disease may have a reason to feel more optimistic about available treatments. A new treatment option that harnesses the body’s immune system is now available for certain patients with advanced NSCLC whose cancer tests positive for PD-L1. Click here for more information.